Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
64 participants
INTERVENTIONAL
2014-12-31
2021-03-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Greater Occipital Nerve Block for Spontaneous Intracranial Hypotension
NCT06374524
Blind Versus Targeted Epidural Patch With Autologous Platelet-rich Plasma for Spontaneous Intracranial Hypotension
NCT07283536
ONSD Changes and Treatment Response After Epidural Blood Patch in Spontaneous Intracranial Hypotension
NCT07085260
The Blood Patch in the Management of Intracranial Hypotension
NCT06498804
Treatment of Post-SCI Hypotension
NCT02919917
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It's a monocentric study of parallel randomized open blind groups. Patients will be recruited by investigators in our headache emergency room. If the diagnose of SIH is confirmed (orthostatic headache from more than 5 days and less than 28 days with a normal MRI or with sign of SIH) study will be proposed.
After a signed information, the patients will be randomized in 2 groups, the investigator is blind of the randomized arm of patient
1. EBP with 24 hours bed rest
2. EBP with 24 hours Trendelenburg position
V1: inclusion V2 : 24 hours before EBP (headache, associated symptoms, HIT6) V3 : randomization and EBP V4 : first evaluation 30 minutes after standing (headaches, associated symptoms) V5 : phone evaluation (safety) D7 V6 : Evaluation at D15 (headache, associated symptoms, safety) V7 : Evaluation at D30 (headache, associated symptoms, control cerebral MRI, HIT6, safety) V8 : last evaluation D60 (headache, associated symptoms,HIT6 safety)
Collection of 2nd EBP, 3rd EBP, 4th EBP throughout the study up to J 92 maximum
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A : 24 hours bed rest
24 hours bed rest
24 hours bed rest
24 hours bed rest after EBP
EBP
Autologous Epidural Blood Patch
B : 24 hours Trendelenburg position
24 hours Trendelenburg position
24 hours Trendelenburg position
Trendelenburg position
EBP
Autologous Epidural Blood Patch
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
24 hours Trendelenburg position
Trendelenburg position
24 hours bed rest
24 hours bed rest after EBP
EBP
Autologous Epidural Blood Patch
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No contraindication for BPE
* Severe or moderate headache within 15 min standing, mild or no headache after 15 min bed rest
* Headache from 5 to 28 days
* Normal or evidence of low CSF on MRI
* Signed informed consent
Exclusion Criteria
* Abnormal MRI
* First BPE for SIH
* The patient has participated in another clinical trial than can interact with the evaluation
* Contraindication of Trendelenburg position
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Caroline ROOS, MD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lariboisiere Hospital - Centre Urgences Céphalées (CUC)
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ferrante E, Arpino I, Citterio A, Wetzl R, Savino A. Epidural blood patch in Trendelenburg position pre-medicated with acetazolamide to treat spontaneous intracranial hypotension. Eur J Neurol. 2010 May;17(5):715-9. doi: 10.1111/j.1468-1331.2009.02913.x. Epub 2009 Dec 29.
Sencakova D, Mokri B, McClelland RL. The efficacy of epidural blood patch in spontaneous CSF leaks. Neurology. 2001 Nov 27;57(10):1921-3. doi: 10.1212/wnl.57.10.1921.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-AO1017-38
Identifier Type: OTHER
Identifier Source: secondary_id
P111118
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.